To study the impact of PI3K inhibition in DCs, Marshall et al. have employed different mouse tumor models and reported that either broad or β-, δ-, or γ-isoform-specific inhibition reduced levels of IL-10 and TGFβ but enhanced IL-12 expression (99). The gene discussed is IL10; the disease is neoplasm.